Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 May 24;13(1):250.
doi: 10.1186/s13104-020-05090-6.

Biphasic human insulin 30 thrice daily, is it reasonable?

Nesreen A Saadeh  1 , Ola Y Al-Azzeh  2 , Yousef S Khader  3
Affiliations
Clinical Trial

Biphasic human insulin 30 thrice daily, is it reasonable?

Nesreen A Saadeh et al. BMC Res Notes. .

Abstract

Objective: To evaluate the efficacy and safety of thrice daily Biphasic Human Insulin 30 (BHI 30) versus the traditional twice-daily regimen in type 2 diabetes mellitus (T2DM) patients. It's a cross over single clinical study. Twenty-two diabetic patients who were already using BHI 30 in twice or thrice daily regimens with or without metformin were included. At the 1st interval; patients continued on their usual insulin regimen as twice or thrice daily injections with adjustment of insulin doses guided by their glucose readings. On the 2nd interval; patients were switched to the other regimen with the same total daily insulin dose redistributed.

Results: There was a significant decrease in HbA1c level (p < 0.05) at the end of the first 3 months of trial regardless on which regimen the patient started, but there was no significant difference in the mean HbA1c reduction in patients when they were on twice daily insulin injections (1.1 ± 1.3) versus the time they were on thrice daily insulin injections (0.8 ± 1.71), p > 0.05. On the other hand, patients had lower average blood glucose readings (mg/dl) when they were on thrice daily insulin injections (161.4 ± 62.7) compared to twice daily regimen (166.0 ± 69.5), p < 0.05.

Keywords: Biphasic human insulin 30; Thrice daily insulin injections; Twice daily insulin injections.

PubMed Disclaimer

Conflict of interest statement

The author declares that they have no competing interests.

Figures

Fig. 1
Fig. 1
Patient distribution
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Shamoon H, Duffy H, Fleischer N, et al. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes and the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986. doi: 10.1056/NEJM199309303291401. - DOI - PubMed
    1. Diabetes Study Group Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes mellitus. Lancet. 1998;352:837–853. doi: 10.1016/S0140-6736(98)07019-6. - DOI - PubMed
    1. Owens DR, Zinman B, Bolli GB. Insulins today and beyond. Lancet. 2001;358:739–746. doi: 10.1016/S0140-6736(01)05842-1. - DOI - PubMed
    1. Clements MR, Tits J, Kinsley BT, et al. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes. Diabetes Obes Metab. 2008;10(3):229–237. doi: 10.1111/j.1463-1326.2006.00687.x. - DOI - PubMed
    1. Yang W, Ji Q, Zhu D, et al. Biphasic Insulin Aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs. Diabetes Care. 2008;31:852–856. doi: 10.2337/dc07-1992. - DOI - PubMed